EODData

MEMBERSHIP REGISTER LOG IN

FRA, 0K4: AKERO THEREP.INC.DL-0001

04 Nov 2025
LAST:

46.65

CHANGE:
 0.07		OPEN:
46.65		HIGH:
46.65		ASK:
0.00		VOLUME:
438
CHG(%):
0.15		PREV:
46.72		LOW:
46.65		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 2546.6546.6546.6546.65438
31 Oct 2546.7246.7246.7246.72438
30 Oct 2546.1146.1146.1146.11438
29 Oct 2546.1946.1946.1946.19438
28 Oct 2545.8645.8645.8645.86438
27 Oct 2546.3946.3946.3946.39438
24 Oct 2546.1646.1645.7545.75438
23 Oct 2546.0546.0546.0546.0520
22 Oct 2546.1446.1446.1446.1420
21 Oct 2546.1546.1546.1546.1520

COMPANY PROFILE

Name:AKERO THEREP.INC.DL-0001
About:Akero Therapeutics, Inc. engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21 that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:601 Gateway Boulevard, South San Francisco, CA, United States, 94080
Website:https://akerotx.com
ISIN:US00973Y1082
LEI:549300SI3KG74LBE2955

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-12.44 
Forward P/E:-12.67 
PEG Ratio:-2.02 
Price to Book:3.64 
Return on Assets:-0.20 
Return on Equity:-0.31 
Shares:79.99M 
Market Cap:3.731B 

TECHNICAL INDICATORS

MA5:46.310.7%
MA10:46.201.0%
MA20:44.993.7%
MA50:41.6612.0%
MA100:43.058.4%
MA200:41.7111.8%
STO9:92.78 
STO14:92.78 
RSI14:46.29
WPR14:-7.22 
MTM14:0.37
ROC14:0.01 
ATR:0.36 
Week High:46.720.2%
Week Low:45.861.7%
Month High:46.990.7%
Month Low:39.2911.8%
Year High:55.3318.6%
Year Low:21.03121.8%
Volatility:20.82